These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22760897)

  • 1. Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist.
    Alessandri SB; Pereira Fde A; Villela RA; Antonini SR; Elias PC; Martinelli CE; Castro Md; Moreira AC; Paula FJ
    Clinics (Sao Paulo); 2012; 67(6):591-6. PubMed ID: 22760897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty.
    Park HK; Lee HS; Ko JH; Hwang IT; Lim JS; Hwang JS
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):743-8. PubMed ID: 22530679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
    Kapteijns-van Kordelaar S; Noordam K; Otten B; van den Bergh J
    Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in bone mineral density and body composition in children with central precocious puberty and early puberty before and after one year of treatment with GnRH agonist.
    Ko JH; Lee HS; Lim JS; Kim SM; Hwang JS
    Horm Res Paediatr; 2011; 75(3):174-9. PubMed ID: 20881364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy.
    van der Sluis IM; Boot AM; Krenning EP; Drop SL; de Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 2002 Feb; 87(2):506-12. PubMed ID: 11836277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density and body composition in Thai Precocious Puberty girls treated with GnRH agonist.
    Wacharasindhu S; Petwijit T; Aroonparkmongkol S; Srivuthana S; Kingpetch K
    J Med Assoc Thai; 2006 Aug; 89(8):1194-8. PubMed ID: 17048429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a Gonadotropin-releasing Hormone Analog to Treat Idiopathic Central Precocious Puberty Is Not Associated with Changes in Bone Structure in Postmenarchal Adolescents.
    Iannetta R; Melo AS; Iannetta O; Marchini JS; Paula FJ; Martinelli CE; Rosa e Silva AC; Ferriani RA; Martins WP; Reis RM
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):304-8. PubMed ID: 26081481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
    Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bone density in girls with precocious and early puberty during treatment with GnRH agonist.
    Assa A; Weiss M; Aharoni D; Mor A; Rachmiel M; Bistritzer T
    J Pediatr Endocrinol Metab; 2011; 24(7-8):505-10. PubMed ID: 21932589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
    Heger S; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4583-90. PubMed ID: 10599723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
    Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
    Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on bone mineral density of gonadotropin releasing hormone analogs used in the treatment of central precocious puberty.
    Unal O; Berberoğlu M; Evliyaoğlu O; Adiyaman P; Aycan Z; Ocal G
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):407-11. PubMed ID: 12705366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.
    Antoniazzi F; Zamboni G; Bertoldo F; Lauriola S; Mengarda F; Pietrobelli A; Tatò L
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1096-101. PubMed ID: 12629090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog.
    Verrotti A; Chiarelli F; Montanaro AF; Morgese G
    Gynecol Endocrinol; 1995 Dec; 9(4):277-81. PubMed ID: 8629454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of a novel mathematical model for the prediction of adult height and age at menarche in girls with idiopathic central precocious puberty.
    Lopes MC; Ramos CO; Latronico AC; Mendonça BB; Brito VN
    Clinics (Sao Paulo); 2018 Jul; 73():e480. PubMed ID: 30066730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Gonadotropin-Releasing Hormone Agonist Treatment on Thyroid Function Tests in Children with Central Idiopathic Precocious Puberty.
    Naderi F; Soheilirad Z; Haghshenas Z
    Med Arch; 2019 Apr; 73(2):101-103. PubMed ID: 31391696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment.
    Nam HK; Kim HR; Rhie YJ; Lee KH
    J Korean Med Sci; 2017 Mar; 32(3):475-479. PubMed ID: 28145651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.